An Ongoing Phase 1 Study of ABT-263; Pharmacokineties, Safety and Anti-Tumor Activity in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL).
- Author(s)
- Roberts, AW; Brown, J; Seymour, JF; Wierda, WG; Kipps, TJ; Xiong, H; Chiu, YL; Busman, T; Knight, RA; Enschede, S; Krivoshik, A; Humerickhouse, R;
- Details
- Publication Year 2008-11-16,Volume 112,Issue #11,Page 1089-1090
- Journal Title
- BLOOD
- Publication Type
- Journal Article
- Publisher
- AMER SOC HEMATOLOGY
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2008-11-16 12:00:00